KRISTA FENDRICK: Open Payments
NPI 1316297286 · MISSION VIEJO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,483 in 345 payments from 21 companies in 2025. Trend: 2023 $960 · 2024 $5,403 · 2025 $7,483
Food & beverage: $7,386Education: $81Travel & lodging: $15
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 56 | $1,315 |
| Teva Pharmaceuticals USA, Inc. | 54 | $921 |
| ABBVIE INC. | 49 | $814 |
| Vanda Pharmaceuticals Inc. | 24 | $802 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 24 | $523 |
| Axsome Therapeutics, Inc. | 18 | $461 |
| E.R. Squibb & Sons, L.L.C. | 18 | $440 |
| Alkermes, Inc. | 18 | $435 |
| Otsuka America Pharmaceutical, Inc. | 17 | $430 |
| Janssen Pharmaceuticals, Inc | 12 | $312 |
Products named: INGREZZA, VRAYLAR, AUSTEDO XR, CAPLYTA, COBENFY, FANAPT, Auvelity, HETLIOZ.
Industry payments across CA — which companies pay providers there.
